Bone BiologicsBBLG
13F holders, Q2 2026 (June 30)3holders
1new positions
1sold out
1famous investor
$1.37avg. 13F price*
At the end of Q2 2026, 3 institutions reported holding Bone Biologics Corp. (BBLG) in their 13F filings, unchanged from Q1 2026. 1 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($33K), Tower Research Capital LLC (TRC) ($3K) and SBI Securities Co., Ltd. ($315). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp.
- CUSIP
- 098070600
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $33K |
| Exits | 1 | $62 |
All 13F filers, Q1 2026 → Q2 2026: 23,879 shares bought and 2,229 shares sold, net +21,650 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Citadel Advisors | 0.00% | New | 23,879 | $33K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -52.7% | 1,953 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 230 | $315 |
"% of holder's portfolio" is BBLG's weight in each manager's 13F, not the share of Bone Biologics Corp. the manager owns.